Effects of Nitric Oxide Synthase 3 Gene Polymorphisms on Cardiovascular Events in a General Japanese Population　― The Yamagata (Takahata) Study ―-Reference-Cited by-同舟云学术

Effects of Nitric Oxide Synthase 3 Gene Polymorphisms on Cardiovascular Events in a General Japanese Population　― The Yamagata (Takahata) Study ―

Published:2022-05-10 Issue:5 Volume:4 Page:222-229
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Saito Yuji¹,Otaki Yoichiro¹,Watanabe Tetsu¹,Wanezaki Masahiro¹,Kutsuzawa Daisuke¹,Kato Shigehiko¹,Tamura Harutoshi¹,Nishiyama Satoshi¹,Arimoto Takanori¹,Takahashi Hiroki¹,Ueno Yoshiyuki²,Konta Tsuneo³,Watanabe Masafumi¹

Affiliation:

1. Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine

2. Global Center of Excellence, Yamagata University School of Medicine

3. Department of Public Health and Hygiene, Yamagata University Graduate School of Medical Science

Publisher

Japanese Circulation Society

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/circrep/4/5/4_CR-21-0159/_pdf

Reference26 articles.

1. 1. Laslett LJ, Alagona P, Clark BA, Drozda JP, Saldivar F, Wilson SR, et al. The worldwide environment of cardiovascular disease: Prevalence, diagnosis, therapy, and policy issues: A report from the American College of Cardiology. J Am Coll Cardiol 2012; 60: S1–S49.

2. 2. Ueda Y, Tahara Y, Itoh T, Tsujita K, Sakuma M, Amano T, et al. New strategy to prevent acute myocardial infarction by public education: A position statement of the committee on public education about emergency medical care of the Japanese Circulation Society. Circ J 2021; 85: 319–322.

3. 3. Itoh H, Kaneko H, Kiriyama H, Kamon T, Fujiu K, Morita K, et al. Metabolically healthy obesity and the risk of cardiovascular disease in the general population: Analysis of a nationwide epidemiological database. Circ J 2021; 85: 914–920.

4. 4. Kotseva K, De Bacquer D, De Backer G, Rydén L, Jennings C, Gyberg V, et al. Lifestyle and risk factor management in people at high risk of cardiovascular disease: A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions. Eur J Prev Cardiol 2016; 23: 2007–2018.

5. 5. McCarthy JJ, Hilfiker R. The use of single-nucleotide polymorphism maps in pharmacogenomics. Nat Biotechnol 2000; 18: 505–508.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Selected Nitric Oxide Synthase Polymorphisms on the Risk of Developing Diabetic Nephropathy;Antioxidants;2024-07-13

2. Glu298Asp variant of the endothelial nitric oxide synthase gene and acute coronary syndrome or premature coronary artery disease: A systematic review and meta-analysis;Nitric Oxide;2023-09